APOBIOLOGIX Trademark

Trademark Overview

On Wednesday, March 11, 2015, a trademark application was filed for APOBIOLOGIX with the United States Patent and Trademark Office. The USPTO has given the APOBIOLOGIX trademark a serial number of 86560396. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 18, 2023. This trademark is owned by Apotex Technologies Inc.. The APOBIOLOGIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceuticals for [hemopoetic] *hematopoietic* growth factors used for stimulating white blood cell production and for the treatment of proliferative disorders, namely, angiogenic disorders including cancer
apobiologix

General Information

Serial Number86560396
Word MarkAPOBIOLOGIX
Filing DateWednesday, March 11, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 18, 2023
Registration Number5135257
Registration DateTuesday, February 7, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2016

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 4, " hemopoetic" should be deleted, and hematopoietic should be inserted.
Goods and ServicesPharmaceutical preparations, namely, pharmaceuticals for [hemopoetic] *hematopoietic* growth factors used for stimulating white blood cell production and for the treatment of proliferative disorders, namely, angiogenic disorders including cancer
Pseudo MarkAPOTEX BIOLOGIC; APO BIOLOGIX

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 18, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAPOTEX INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressTORONTO M9L1T9
CA
Party NameApotex Technologies Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9L1T9
CA
Party NameApotex Technologies Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9L1T9
CA
Party NameApotex Technologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9L1T9
CA

Trademark Events

Event DateEvent Description
Friday, August 18, 2023CANCELLED SEC. 8 (6-YR)
Wednesday, July 19, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, July 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 19, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 19, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 19, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 7, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, June 19, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 28, 2017CORRECTION UNDER SECTION 7 ¿ PROCESSED
Monday, June 26, 2017ASSIGNED TO PARALEGAL
Friday, April 21, 2017TEAS SECTION 7 REQUEST RECEIVED
Tuesday, February 7, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, January 3, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, November 22, 2016NOTICE OF ALLOWANCE CANCELLED
Tuesday, November 22, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 10, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 5, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 4, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 28, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 28, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 28, 2016ASSIGNED TO LIE
Monday, March 14, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 28, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 28, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, October 28, 2015SUSPENSION LETTER WRITTEN
Tuesday, October 6, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 5, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 5, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 19, 2015NON-FINAL ACTION E-MAILED
Tuesday, May 19, 2015NON-FINAL ACTION WRITTEN
Thursday, May 14, 2015ASSIGNED TO EXAMINER
Tuesday, March 24, 2015NOTICE OF PSEUDO MARK E-MAILED
Monday, March 23, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 14, 2015NEW APPLICATION ENTERED

Related Keywords

apobiologix disorders namely cell treatment production proliferative angiogenic cancer including blood